Comparison of two red-cell transfusion strategies after pediatric cardiac surgery: a subgroup analysis

Ariane Willems1, Karen Harrington, Jacques Lacroix

  • 1Pediatric Intensive Care Unit, Department of Pediatrics, Université de Montréal, Montréal, QC, Canada.

Critical Care Medicine
|October 1, 2009
PubMed

Insights

A restrictive red-cell transfusion strategy did not significantly differ from a liberal approach in preventing multiple organ dysfunction syndrome in pediatric cardiac surgery patients. This finding suggests current transfusion thresholds may be too high for this population.

Area of Science:

  • Pediatric critical care medicine
  • Cardiovascular surgery
  • Transfusion medicine

Background:

  • The optimal red-cell transfusion threshold for pediatric patients undergoing cardiac surgery remains unclear.
  • Multiple organ dysfunction syndrome (MODS) is a significant complication in this patient population.

Purpose of the Study:

  • To compare the impact of restrictive versus liberal red-cell transfusion strategies on new or progressive MODS in children after cardiac surgery.

Main Methods:

  • A randomized controlled trial was conducted within pediatric intensive care units.
  • Participants were a subgroup of pediatric cardiac surgery patients from the TRIPICU study.
  • Patients with hemoglobin < or = 95 g/L were randomized to restrictive (<70 g/L) or liberal (95 g/L) transfusion thresholds.

Main Results:

  • No significant difference in new or progressive MODS was observed between the restrictive (12.7%) and liberal (6.5%) groups (p = .36).
  • Length of pediatric intensive care unit stay and 28-day mortality were also similar between groups.
  • Mean hemoglobin levels were consistently lower in the restrictive group post-randomization.

Conclusions:

  • In pediatric cardiac surgery patients, a restrictive red-cell transfusion strategy did not lead to a significant increase in MODS compared to a liberal strategy.
  • The study suggests that current transfusion thresholds may not be optimal for this specific patient group, but further definitive evidence is needed.
Abstract